Go here to read the rest: Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
Go here to read the rest: Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
See more here: Noema Pharma Appoints Robert Lasser, M.D., as Chief Medical Officer
See original here: Grifols Completes Cohort 1 in Clinical Study of Alpha-1 15%, Evaluating First-in-Human Subcutaneous Dosing Option for Patients with Alpha1-Antitrypsin...
Link: Evaxion Presents Proof-of-Principle for Its Unique AI Model Predicting Responses to Cancer Immunotherapy
Original post: SciSparc Celebrates Major Breakthrough: Positive Results Show its Treatment has a Remarkable Impact on Alzheimer's Agitation
Read more from the original source: GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Original post: Dr. Peter Staats to Host Analyst Day on the Science Behind gammaCore™ Non-Invasive Vagus Nerve Stimulation (nVNS) on Tuesday, November 21, 2023
Visit link: Athira Pharma Presents Preclinical Data Highlighting Fosgonimeton’s Neuroprotective Effects Against Amyloid-β-Induced Pathological Alterations and...
Read more: Carmot Therapeutics Commenced Phase 2 Clinical Trial of Novel Dual GLP-1/GIP Receptor Agonist CT-868 for the Treatment of Type 1 Diabetes
View post: Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference
Recent Comments